In patients with LCC or SCLC, the expressions of MEF2A were significantly lower, compared with non-cancer tissues (Fig. 1b, c, p < 0.01, and 0.001, respectively). The gene discussed is MEF2A; the disease is leukoencephalopathy with calcifications and cysts.